Pharmacology, 3rd Edition
Description:
For courses covering pharmacology, and/or preparing nursing students for the pharmacology components of the NCLEX-RN® examination.
PEARSON REVIEWS & RATIONALES: PHARMACOLOGY WITH "NURSING REVIEWS & RATIONALES", 3/e provides a clear, concentrated, and up-to-date review of today’s “need to know” knowledge for effective pharmacology. Developed and reviewed by a large team of nurse educators, it can be used by current nursing students as a study aid, for NCLEX-RN® exam preparation, or by practicing nurses seeking comprehensive yet concise review of this discipline. Fully reflective of the current (2010) NCLEX-RN® Test Plan, it begins by introducing basic pharmacological principles and safety issues. Next, it provides complete chapters on each of the following: anti-infectives; antineoplastics; blood modifiers; medications for the cardiac, endocrine, gastrointestinal, immune, integumentary, neurological, musculoskeletal, renal, respiratory, and reproductive systems; psychiatric medications; visual and auditory medications; and herbal agents. This text comes with a complete support package, including access to additional questions and the complete eText online, and a tear-out NursingNotes card for clinical reference and quick review.
Best prices to buy, sell, or rent ISBN 9780133045994
Frequently Asked Questions about Pharmacology, 3rd Edition
The price for the book starts from $7.19 on Amazon and is available from 27 sellers at the moment.
If you’re interested in selling back the Pharmacology, 3rd Edition book, you can always look up BookScouter for the best deal. BookScouter checks 30+ buyback vendors with a single search and gives you actual information on buyback pricing instantly.
As for the Pharmacology, 3rd Edition book, the best buyback offer comes from and is $ for the book in good condition.
The Pharmacology, 3rd Edition book is in very low demand now as the rank for the book is 3,028,172 at the moment. A rank of 1,000,000 means the last copy sold approximately a month ago.
Not enough insights yet.